Pfizer Slams Appeal In Off-Label FCA Case In 1st Circ.

By Chuck Stanley (November 9, 2016, 6:02 PM EST) -- Two former sales reps failed to present evidence Pfizer used kickbacks to push off-label uses of an antipsychotic drug despite having ample opportunity to present their case, the pharmaceutical company said Tuesday in a brief urging the First Circuit to toss the workers' False Claims Act suit....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Attached Documents

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only


Subscribers Only

Nature of Suit

Subscribers Only


Subscribers Only

Date Filed

Subscribers Only

Law Firms


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!